ZA824340B - Compositions for treating glaucoma - Google Patents

Compositions for treating glaucoma

Info

Publication number
ZA824340B
ZA824340B ZA824340A ZA824340A ZA824340B ZA 824340 B ZA824340 B ZA 824340B ZA 824340 A ZA824340 A ZA 824340A ZA 824340 A ZA824340 A ZA 824340A ZA 824340 B ZA824340 B ZA 824340B
Authority
ZA
South Africa
Prior art keywords
compositions
treating glaucoma
glaucoma
treating
Prior art date
Application number
ZA824340A
Other languages
English (en)
Inventor
W Matier
Original Assignee
American Hospital Supply Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Hospital Supply Corp filed Critical American Hospital Supply Corp
Publication of ZA824340B publication Critical patent/ZA824340B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ZA824340A 1981-06-23 1982-06-18 Compositions for treating glaucoma ZA824340B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/276,658 US4454154A (en) 1981-06-23 1981-06-23 Method for treating glaucoma by the topical administration of selectively metabolized beta-blocking agents

Publications (1)

Publication Number Publication Date
ZA824340B true ZA824340B (en) 1983-04-27

Family

ID=23057573

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA824340A ZA824340B (en) 1981-06-23 1982-06-18 Compositions for treating glaucoma

Country Status (17)

Country Link
US (1) US4454154A (US06236872-20010522-M00003.png)
EP (1) EP0082873B1 (US06236872-20010522-M00003.png)
JP (1) JPH0653663B2 (US06236872-20010522-M00003.png)
AU (1) AU565752B2 (US06236872-20010522-M00003.png)
CA (1) CA1188224A (US06236872-20010522-M00003.png)
CH (1) CH654205A5 (US06236872-20010522-M00003.png)
ES (1) ES8401928A1 (US06236872-20010522-M00003.png)
GB (1) GB2111387B (US06236872-20010522-M00003.png)
GR (1) GR76847B (US06236872-20010522-M00003.png)
IL (1) IL66070A (US06236872-20010522-M00003.png)
IT (1) IT1156058B (US06236872-20010522-M00003.png)
NL (1) NL8220252A (US06236872-20010522-M00003.png)
NZ (1) NZ200972A (US06236872-20010522-M00003.png)
PH (1) PH18970A (US06236872-20010522-M00003.png)
SE (1) SE462075B (US06236872-20010522-M00003.png)
WO (1) WO1983000014A1 (US06236872-20010522-M00003.png)
ZA (1) ZA824340B (US06236872-20010522-M00003.png)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5334601A (en) * 1984-03-14 1994-08-02 Bodor Nicholas S Soft β-adrenergic blocking agents
US5202347A (en) * 1984-03-14 1993-04-13 Bodor Nicholas S Soft β-adrenergic blocking agents
US5135926A (en) * 1984-03-14 1992-08-04 Bodor Nicholas S Soft β-adrenergic blocking agents
US4609663A (en) * 1984-09-11 1986-09-02 Alcon Laboratories, Inc. Aldose reductase inhibitors useful in glaucoma therapy
ES2042625T5 (es) * 1987-04-03 2000-07-16 Univ Columbia Uso de una prostaglandina en combinacion con un agente bloqueante adrenergico para la reduccion de presion intraocular.
CA1334168C (en) * 1988-04-26 1995-01-31 Louis M. De Santis Antiglaucoma compositions containing combinations of .alpha.-2 agonists and .beta. blockers
US4857552A (en) * 1988-06-08 1989-08-15 E. I. Du Pont De Nemours And Co. Stable pharmaceutical composition
US5536749A (en) * 1994-10-13 1996-07-16 Sl Pharmaceuticals, Inc. Method for attenuation of sympathetic nervous system activity or onset of migraine by selectively metabolized beta-blocking agents
US6197817B1 (en) 1999-01-22 2001-03-06 Selectus Pharmaceuticals, Inc. Phenylpropionic acids and esters: compounds and methods for inducing beta-blockade for the treatment of cardiac disorders
JP2008500359A (ja) * 2004-05-25 2008-01-10 オセラ・フアーマシユーチカルズ・インコーポレーテツド 眼選択的薬剤（ｏｃｕｌｏｓｅｌｅｃｔｉｖｅｄｒｕｇ）およびプロドラッグ

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1593762A1 (de) * 1967-02-06 1972-06-08 Boehringer Sohn Ingelheim Verfahren zur Herstellung von neuen substituierten 1-Phenoxy-2-hydroxy-3-alkylaminopropanen
US3868460A (en) * 1967-02-06 1975-02-25 Boehringer Sohn Ingelheim Therapeutic compositions and method
US3740444A (en) * 1968-01-25 1973-06-19 Boehringer Sohn Ingelheim Therapeutic compositions and method
GB1285038A (en) * 1969-02-21 1972-08-09 Ici Ltd Alkanolamine derivatives
DE1922003C3 (de) * 1969-04-30 1979-10-11 Boehringer Mannheim Gmbh, 6800 Mannheim N-(3-Aryloxy-2-hydroxypropyl)-aminocarbonsäuren, deren Ester, Amide und Salze, Verfahren zur Herstellung dieser Verbindungen und deren Verwendung bei der Bekämpfung von Herzinsuffizienz
DE2048838A1 (de) * 1970-10-05 1972-04-06 C H Boehnnger Sohn, 6507 Ingel heim Neue 1 Phenoxy 2 hydroxy 3 hydroxyal kylaminopropane und Verfahren zu ihrer Her stellung
FR2132570B1 (US06236872-20010522-M00003.png) * 1971-04-09 1974-08-02 Lipha
JPS4875539A (US06236872-20010522-M00003.png) * 1972-01-12 1973-10-11
JPS49247A (US06236872-20010522-M00003.png) * 1972-04-17 1974-01-05
US3839584A (en) * 1972-08-31 1974-10-01 Interx Research Corp Pharmaceutical compositions containing a novel ester of ((methylamino)methyl)benzyl alcohol and methods of using same
AT330150B (de) * 1973-02-28 1976-06-10 Boehringer Sohn Ingelheim Verfahren zur herstellung von neuen 1-phenoxy-2-hydroxy -3- propargylaminopropanen und von deren saureadditionssalzen
US3825583A (en) * 1973-04-26 1974-07-23 Interx Research Corp Ester of 3-hydroxy-alpha-((methylamino)methyl)benzyl alcohol
US4195085A (en) * 1975-09-26 1980-03-25 Merck & Co., Inc. Compositions and methods for treating glaucoma by the topical administration of t-butylamino-3-(4-morpholino-1,2,5-thiadiazol-3-yloxy-2-phopanol hydrogen maleate
US4146638A (en) * 1976-02-17 1979-03-27 Boehringer Ingelheim Gmbh N-(3-phenoxy-2-hydroxy-propyl)-n-(2-phenyl-2-hydroxy-ethyl)-amines
US4191765A (en) * 1976-05-25 1980-03-04 Hoechst Aktiengesellschaft 1-Aryloxy-2-hydroxy-3-aminopropanes
US4080471A (en) * 1976-06-25 1978-03-21 Aktiebolaget Hassle Use of substituted isopropylaminopropanols for inducing inotropic effects of the human heart
DE2752659A1 (de) * 1976-12-07 1978-06-08 Sandoz Ag Neue tetralinderivate, ihre herstellung und verwendung
US4127674A (en) * 1977-03-21 1978-11-28 Allergan Pharmaceuticals, Inc. Method of treatment for glaucoma
DE2962112D1 (en) * 1978-02-08 1982-03-25 Ici Plc Alkanolamine derivatives, process for their preparation and pharmaceutical compositions containing them
SE8004088L (sv) * 1980-06-02 1981-12-03 Haessle Ab Nya substituerade 3-fenoxi-l-alkoxikarbonylalkylamino-propanol-2-er med beta-receptorblockerande egenskaper samt forfarande for deras framstellning, farmaceutiska beredningar innehallande desamma och metod att ...
SE8004087L (sv) * 1980-06-02 1981-12-03 Haessle Ab Nya parasubstituerade 3-fenoxi-1-alkylaminopropanol-2-er med betareceptorblockerande egenskaper, samt forfarande for deras framstellning, farmaceutiska beredningar innehallande desamma, och metod att behandla akut ...
US4387103A (en) * 1980-11-28 1983-06-07 American Hospital Supply Corporation Method for treatment or prophylaxis of cardiac disorders

Also Published As

Publication number Publication date
AU8737482A (en) 1983-01-18
GR76847B (US06236872-20010522-M00003.png) 1984-09-04
IL66070A (en) 1987-03-31
EP0082873B1 (en) 1988-12-07
ES513387A0 (es) 1984-01-01
CH654205A5 (de) 1986-02-14
JPH0653663B2 (ja) 1994-07-20
EP0082873A1 (en) 1983-07-06
US4454154A (en) 1984-06-12
IL66070A0 (en) 1982-09-30
WO1983000014A1 (en) 1983-01-06
GB2111387B (en) 1986-02-05
SE8300913L (en) 1983-02-18
PH18970A (en) 1985-11-26
ES8401928A1 (es) 1984-01-01
JPS58500996A (ja) 1983-06-23
IT8267796A0 (it) 1982-06-22
EP0082873A4 (en) 1983-11-11
NZ200972A (en) 1986-10-08
GB8303061D0 (en) 1983-03-09
SE462075B (sv) 1990-05-07
CA1188224A (en) 1985-06-04
NL8220252A (nl) 1983-05-02
SE8300913D0 (sv) 1983-02-18
IT1156058B (it) 1987-01-28
AU565752B2 (en) 1987-09-24
GB2111387A (en) 1983-07-06

Similar Documents

Publication Publication Date Title
GB2111040B (en) Water treating compositions
GB8511539D0 (en) Compositions for treating textiles
IL66069A0 (en) Compositions for treating glaucoma
GB2110532B (en) Bendazac compositions for treatment of cataract
JPS57212118A (en) Ophthalmic composition
GB2042338B (en) Compositions for treating glaucoma
DE3262847D1 (en) Heat-polymerisable compositions
IL66070A0 (en) Compositions for treating glaucoma
JPS57181011A (en) Nadrol composition for glaucoma treatment
GB2112786B (en) Compositions for treating glaucoma
GB2129841B (en) Backizing compositions for textiles
DE3360742D1 (en) Sterilising compositions
JPS57210098A (en) Composition for treating substrate
GB8411035D0 (en) Formaldehyde-binding compositions
GB2105190B (en) Light-screen compositions
DE3263502D1 (en) Flavour-release compositions
DE3161167D1 (en) Process for the preparation of 1,2-benzisothiazoles
GB2079153B (en) Acetal-acid compositions
DE3171421D1 (en) Anaerobically-curing compositions
GB2110088B (en) Compositions for the treatment of acne
DE3374320D1 (en) Compositions for rust treatment
ZA8032B (en) Compositions for treating glaucoma
JPS57175362A (en) Pasturizing composition
GB2067403B (en) Bezodiazepine compositions
JPS5761651A (en) Under treatment composition